353 related articles for article (PubMed ID: 17319096)
1. Ongoing clinical trials of the pleiotropic effects of statins.
Davignon J; Leiter LA
Vasc Health Risk Manag; 2005; 1(1):29-40. PubMed ID: 17319096
[TBL] [Abstract][Full Text] [Related]
2. [The pleiotropic effects of statins].
Wolfovitz E
Harefuah; 2005 Aug; 144(8):577-82, 597. PubMed ID: 16146158
[TBL] [Abstract][Full Text] [Related]
3. Non-lipid effects of statins: emerging new indications.
Yildirir A; Müderrisoglu H
Curr Vasc Pharmacol; 2004 Oct; 2(4):309-18. PubMed ID: 15320810
[TBL] [Abstract][Full Text] [Related]
4. Pleiotropic effects of statins: stabilization of the vulnerable atherosclerotic plaque?
Akdim F; van Leuven SI; Kastelein JJ; Stroes ES
Curr Pharm Des; 2007; 13(10):1003-12. PubMed ID: 17430164
[TBL] [Abstract][Full Text] [Related]
5. Beneficial cardiovascular pleiotropic effects of statins.
Davignon J
Circulation; 2004 Jun; 109(23 Suppl 1):III39-43. PubMed ID: 15198965
[TBL] [Abstract][Full Text] [Related]
6. Statins and stroke prevention.
Paciaroni M; Hennerici M; Agnelli G; Bogousslavsky J
Cerebrovasc Dis; 2007; 24(2-3):170-82. PubMed ID: 17596685
[TBL] [Abstract][Full Text] [Related]
7. Statins Therapy for Connective Tissue Diseases: New Therapeutic Opportunities.
Kotyla PJ; Kucharz EJ
Endocr Metab Immune Disord Drug Targets; 2018 Feb; 18(2):135-147. PubMed ID: 29149821
[TBL] [Abstract][Full Text] [Related]
8. Pleiotropic effects of statins: do they matter?
Gotto AM; Farmer JA
Curr Opin Lipidol; 2001 Aug; 12(4):391-4. PubMed ID: 11507323
[TBL] [Abstract][Full Text] [Related]
9. Pleiotropic effects of statins.
Liao JK; Laufs U
Annu Rev Pharmacol Toxicol; 2005; 45():89-118. PubMed ID: 15822172
[TBL] [Abstract][Full Text] [Related]
10. [Do the pleiotropic effects of statins have a clinical significance?].
Vergès B
Arch Mal Coeur Vaiss; 2004 Dec; 97(12):1231-5. PubMed ID: 15669365
[TBL] [Abstract][Full Text] [Related]
11. The pleiotropic effects of HMG-CoA reductase inhibitors: their role in osteoporosis and dementia.
Waldman A; Kritharides L
Drugs; 2003; 63(2):139-52. PubMed ID: 12515562
[TBL] [Abstract][Full Text] [Related]
12. Statins: potential new indications in inflammatory conditions.
Endres M
Atheroscler Suppl; 2006 Apr; 7(1):31-5. PubMed ID: 16503422
[TBL] [Abstract][Full Text] [Related]
13. [The non-lipid effects of statins].
Paragh G; Márk L; Katona E
Orv Hetil; 2004 Sep; 145(37):1903-10. PubMed ID: 15493621
[TBL] [Abstract][Full Text] [Related]
14. Models for describing relations among the various statin drugs, low-density lipoprotein cholesterol lowering, pleiotropic effects, and cardiovascular risk.
Robinson JG
Am J Cardiol; 2008 Apr; 101(7):1009-15. PubMed ID: 18359323
[TBL] [Abstract][Full Text] [Related]
15. The pleiotropic effects of the hydroxy-methyl-glutaryl-CoA reductase inhibitors in cardiovascular disease: a comprehensive review.
Mihos CG; Salas MJ; Santana O
Cardiol Rev; 2010; 18(6):298-304. PubMed ID: 20926939
[TBL] [Abstract][Full Text] [Related]
16. Pleiotropic effects of statins: evidence for benefits beyond LDL-cholesterol lowering.
Marzilli M
Am J Cardiovasc Drugs; 2010; 10 Suppl 1():3-9. PubMed ID: 21391728
[TBL] [Abstract][Full Text] [Related]
17. Statins and the endothelium.
Ii M; Losordo DW
Vascul Pharmacol; 2007 Jan; 46(1):1-9. PubMed ID: 16920035
[TBL] [Abstract][Full Text] [Related]
18. Effects of statins beyond lipid lowering: potential for clinical benefits.
Almuti K; Rimawi R; Spevack D; Ostfeld RJ
Int J Cardiol; 2006 Apr; 109(1):7-15. PubMed ID: 16054715
[TBL] [Abstract][Full Text] [Related]
19. Beneficial effects of statins on endothelial dysfunction and vascular stiffness.
Dilaveris P; Giannopoulos G; Riga M; Synetos A; Stefanadis C
Curr Vasc Pharmacol; 2007 Jul; 5(3):227-37. PubMed ID: 17627566
[TBL] [Abstract][Full Text] [Related]
20. Do the pleiotropic effects of statins in the vasculature predict a role in inflammatory diseases?
McCarey DW; Sattar N; McInnes IB
Arthritis Res Ther; 2005; 7(2):55-61. PubMed ID: 15743490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
